NIH-Funded Study Tests PEDF Peptide Eye Drops for Retinitis Pigmentosa and AMD
The PEDF-based eye drops significantly slowed photoreceptor loss in both animal and human-derived retinal models. Retinal degeneration is notoriously hard…
FDA Grants Fast Track Designation to Oral Treatment for Retinitis Pigmentosa
Nacuity’s NPI-001 investigational mutation-agnostic oral tablet therapy for retinitis pigmentosa has been greenlit for speedier approval by the FDA. The…
latest posts
